567 related articles for article (PubMed ID: 22275758)
1. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation.
Riera MF; Regueira M; Galardo MN; Pellizzari EH; Meroni SB; Cigorraga SB
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E914-23. PubMed ID: 22275758
[TBL] [Abstract][Full Text] [Related]
2. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
Parrales A; López E; Lee-Rivera I; López-Colomé AM
Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
[TBL] [Abstract][Full Text] [Related]
3. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
4. Follicle-stimulating hormone amplifies insulin-like growth factor I-mediated activation of AKT/protein kinase B signaling in immature rat Sertoli cells.
Khan SA; Ndjountche L; Pratchard L; Spicer LJ; Davis JS
Endocrinology; 2002 Jun; 143(6):2259-67. PubMed ID: 12021190
[TBL] [Abstract][Full Text] [Related]
5. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
6. FSH activates phosphatidylinositol 3-kinase/protein kinase B signaling pathway in 20-day-old Sertoli cells independently of IGF-I.
Meroni SB; Riera MF; Pellizzari EH; Galardo MN; Cigorraga SB
J Endocrinol; 2004 Feb; 180(2):257-65. PubMed ID: 14765977
[TBL] [Abstract][Full Text] [Related]
7. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells.
Chen YJ; Hsiao PW; Lee MT; Mason JI; Ke FC; Hwang JJ
J Endocrinol; 2007 Feb; 192(2):405-19. PubMed ID: 17283241
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
9. Follicle-stimulating hormone-induced aromatase in immature rat Sertoli cells requires an active phosphatidylinositol 3-kinase pathway and is inhibited via the mitogen-activated protein kinase signaling pathway.
McDonald CA; Millena AC; Reddy S; Finlay S; Vizcarra J; Khan SA; Davis JS
Mol Endocrinol; 2006 Mar; 20(3):608-18. PubMed ID: 16269516
[TBL] [Abstract][Full Text] [Related]
10. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells.
Kayampilly PP; Menon KM
Endocrinology; 2007 Aug; 148(8):3950-7. PubMed ID: 17510244
[TBL] [Abstract][Full Text] [Related]
11. Follicle-stimulating hormone inhibits adenosine 5'-monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt-dependent pathway.
Kayampilly PP; Menon KM
Endocrinology; 2009 Feb; 150(2):929-35. PubMed ID: 18927218
[TBL] [Abstract][Full Text] [Related]
12. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
14. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling pathways involved in the relaxin-induced proliferation of rat Sertoli cells.
Nascimento AR; Pimenta MT; Lucas TF; Royer C; Porto CS; Lazari MF
Eur J Pharmacol; 2012 Sep; 691(1-3):283-91. PubMed ID: 22819701
[TBL] [Abstract][Full Text] [Related]
16. Regulation of rat Sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway.
Meroni SB; Riera MF; Pellizzari EH; Cigorraga SB
J Endocrinol; 2002 Aug; 174(2):195-204. PubMed ID: 12176658
[TBL] [Abstract][Full Text] [Related]
17. Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells.
Lécureuil C; Tesseraud S; Kara E; Martinat N; Sow A; Fontaine I; Gauthier C; Reiter E; Guillou F; Crépieux P
Mol Endocrinol; 2005 Jul; 19(7):1812-20. PubMed ID: 15774499
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW
Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between FSH and relaxin at the end of the proliferative stage of rat Sertoli cells.
Nascimento AR; Macheroni C; Lucas TF; Porto CS; Lazari MF
Reproduction; 2016 Dec; 152(6):613-628. PubMed ID: 27601715
[TBL] [Abstract][Full Text] [Related]
20. 4-Nonylphenol induces autophagy and attenuates mTOR-p70S6K/4EBP1 signaling by modulating AMPK activation in Sertoli cells.
Duan P; Hu C; Quan C; Yu T; Huang W; Chen W; Tang S; Shi Y; Martin FL; Yang K
Toxicol Lett; 2017 Feb; 267():21-31. PubMed ID: 28041982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
